Aurobindo Pharma completes acquisition of US-based Lannett Company
Lannett has a cGMP manufacturing facility in Indiana with an annual capacity of about 3.6 bn tablets
open_in_new
open_in_new
Read Full Article on Hindu BusinessLine
Original Article
Published on Hindu BusinessLine
● Neutral
Source: Hindu BusinessLine
open_in_new